NCT04314401 2026-04-13National Cancer Institute "Cancer Moonshot Biobank"National Cancer Institute (NCI)Active not recruiting1,600 enrolled
NCT04673448 2026-01-09Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerUniversity of WashingtonPhase 1 Active not recruiting18 enrolled
NCT06714617 2025-11-04Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid TumorsSystImmune Inc.Phase 1 Active not recruiting120 enrolled
NCT03872947 2025-08-03A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsToray Industries, IncPhase 1 Active not recruiting138 enrolled
NCT04616534 2025-05-22Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Active not recruiting14 enrolled
NCT05179824 2025-05-06Tempus Priority Study: A Pan-tumor Observational StudyTempus AIActive not recruiting1,000 enrolled